Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 170
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00161213 | Gemcitabine and Imatinib Mesylate as First-Line Therapy in Patients With Locally Adv. or Metastatic Pancreatic Cancer | ||
| NCT01032590 | Internet-Based Weight-Loss Program for Colorectal Cancer Survivors | ||
| NCT00176501 | Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer | ||
| NCT02688192 | Mobile Health Fitness Program for Adolescent and Young Adult Childhood Cancer Survivors | ||
| NCT01018836 | Riluzole and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases | ||
| NCT02015104 | Study of Bacillus Calmette-Guerin (BCG) Combined With PANVAC Versus BCG Alone in Adults With High Grade Non-Muscle Invasive Bladder Cancer Who Failed At Least 1 Course of BCG | ||
| NCT06763770 | Digital Self-Management and Peer Mentoring Intervention | ||
| NCT02315196 | Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients With Triple Negative Stage II-III Breast Cancer | ||
| NCT02202044 | Sequential Intravesical Bacillus Calmette-Guérin and Electromotive Mitomycin-C After Transuretheral Resection | ||
| NCT02458716 | Cytoreductive Prostatectomy in Treating Patients With Newly Diagnosed, Metastatic Prostate Cancer | ||
| NCT00866840 | Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery | ||
| NCT04211259 | Loratadine for the Reduction of G-CSF Induced Bone Pain in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization | ||
| NCT00786682 | Docetaxel and Hydroxychloroquine in Treating Patients With Metastatic Prostate Cancer | ||
| NCT01006369 | Hydroxychloroquine, Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer | ||
| NCT03108911 | Gluten Free Diet in Diminishing Side Effects Patients With Acute Myeloid Leukemia Undergoing Induction Chemotherapy | ||
| NCT01326286 | Comparative Effectiveness Analysis of Surgery and Radiation (CEASAR) for Localized Prostate Cancer | ||
| NCT04285268 | Rituximab, Venetoclax, and Bortezomib for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma | ||
| NCT00934895 | Phase I/II Study of Weekly Abraxane and RAD001 in Women With Locally Adv. or Metastatic Breast Ca | ||
| NCT05785780 | Aim 3, Optimizing CRC Screening in Patients With Diabetes in Safety-net Primary Care Settings | ||
| NCT06002282 | HPV Vaccine Confident Families | ||
| NCT06518837 | Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer | ||
| NCT00176488 | Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer | ||
| NCT02620527 | Concordance Between ctDNA Assay and FoundationOne | ||
| NCT00578240 | Molecular Studies and Clinical Correlations in Human Prostatic Disease | ||
| NCT04179227 | Focus Group in Collecting Feedbacks From Indoor Tanning Bed Users for Social Media-Delivered Intervention Development | ||
| NCT00295932 | Bortezomib, Rituximab, Cyclophosphamide, and Prednisone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma | ||
| NCT03257163 | Pembrolizumab, Capecitabine, and Radiation Therapy in Treating Patients With Mismatch-Repair Deficient and Epstein-Barr Virus Positive Gastric Cancer | ||
| NCT00770666 | Combination Medications vs. Patch Alone for Medically-Ill Smokers | ||
| NCT01652014 | Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies | ||
| NCT00878657 | Intensity-Modulated Radiation Therapy and Gemcitabine in Treating Patients With Locally Advanced Pancreatic Cancer | ||
| NCT01951807 | Psychological Interventions for Gynecologic Cancer | ||
| NCT00496600 | Phase I Study of Patupilone and RAD001 | ||
| NCT03313492 | Modifying Young Adult Skin Cancer Risk and Protective Behaviors | ||
| NCT04445844 | INCMGA00012 and Pelareorep for the Treatment of Metastatic Triple Negative Breast Cancer, IRENE Study | ||
| NCT02526511 | Perfusion Magnetic Resonance Imaging in Diagnosing Patients With Kidney Tumors | ||
| NCT00769652 | Medical Nutrition Therapy or Standard Care in Treating Patients With Lung Cancer, Pancreatic Cancer, or Stage III or Stage IV Prostate Cancer | ||
| NCT02324621 | Continuation of Oral ONC201 in Treating Patients With Advanced Solid Tumors | ||
| NCT00728845 | Hydroxychloroquine, Carboplatin, Paclitaxel, and Bevacizumab in Recurrent Advanced Non-Small Cell Lung Cancer | ||
| NCT02105116 | AML Therapy With Irradiated Allogeneic Cells | ||
| NCT03028948 | Interactive Tailored Website to Promote Sun Protection and Skin Self-Check Behaviors in Patients With Melanoma | ||
| NCT03428802 | Pembrolizumab in Treating Participants With Metastatic, Recurrent or Locally Advanced Cancer and Genomic Instability | ||
| NCT00101062 | Letrozole and Celecoxib in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer | ||
| NCT03228147 | Sensory Evaluation of Oral Nutrition Supplements in Patients at Risk for Mucositis Undergoing Cancer Treatment | ||
| NCT01982058 | Intimacy-Enhancing Couples' Intervention for Localized Prostate Cancer | ||
| NCT04929899 | Bright Ideas - CIN Feasibility Study | ||
| NCT02526498 | Accelerated Partial Breast Radiation Therapy Using High-Dose Rate Brachytherapy in Treating Patients With Early Stage Breast Cancer After Surgery | ||
| NCT00323063 | Gemcitabine +/- Imatinib Mesylate, Patients w/Previously Treated Metastatic Breast Cancer | ||
| NCT00966667 | Health Behaviors in Patients Who Have Finished Treatment for Stage I, Stage II, or Stage III Colorectal Cancer | ||
| NCT04294264 | TAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon Cancer | ||
| NCT00004058 | 12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder |
